Campbell & CO Investment Adviser LLC Ptc Therapeutics, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.3 Billion
- Q3 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 10,137 shares of PTCT stock, worth $506,951. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,137
Previous 57,812
82.47%
Holding current value
$506,951
Previous $1.77 Million
78.72%
% of portfolio
0.03%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding PTCT
# of Institutions
228Shares Held
78.1MCall Options Held
144KPut Options Held
54.8K-
Vanguard Group Inc Valley Forge, PA9.13MShares$456 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$395 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$389 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$370 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$362 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.58B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...